|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Arcturus Therapeutics (NASDAQ: ARCT) through any online brokerage.
The latest price target for Arcturus Therapeutics (NASDAQ: ARCT) was reported by Cantor Fitzgerald on July 2, 2021. The analyst firm set a price target for 71.00 expecting ARCT to rise to within 12 months (a possible 129.03% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Arcturus Therapeutics (NASDAQ: ARCT) is $31 last updated Thu Jul 29 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Arcturus Therapeutics.
There is no upcoming split for Arcturus Therapeutics.
Arcturus Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.